Catalyst Wire Dossier Catalyst Wire Dossier

Fedovapagon

· Vantia Ltd
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Fedovapagon, covering 2014-06-20 to 2018-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) [Phase 2, Phase 3]

See pricing